These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1563378)

  • 21. [Ceftazidime concentration in human prostatic tissue and serum following intravenous injection].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1991 Jun; 37(6):659-62. PubMed ID: 1716410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis.
    Angus BJ; Smith MD; Suputtamongkol Y; Mattie H; Walsh AL; Wuthiekanun V; Chaowagul W; White NJ
    Br J Clin Pharmacol; 2000 Aug; 50(2):184-91. PubMed ID: 10930972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and Pharmacodynamic Analysis of Ceftazidime/Avibactam in Critically Ill Patients.
    Stein GE; Smith CL; Scharmen A; Kidd JM; Cooper C; Kuti J; Mitra S; Nicolau DP; Havlichek DH
    Surg Infect (Larchmt); 2019 Jan; 20(1):55-61. PubMed ID: 30351195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of ceftazidime after intravenous, intramuscular and subcutaneous administration to dogs.
    Monfrinotti A; Ambros L; Prados AP; Kreil V; Rebuelto M
    J Vet Pharmacol Ther; 2010 Apr; 33(2):204-7. PubMed ID: 20444047
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of the mode of intravenous administration on the penetration of ceftazidime into tissues and pleural exudate of rats.
    Miglioli PA; Xerri L; Palatini P
    Pharmacology; 1991; 43(5):242-6. PubMed ID: 1784624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The penetration of ceftazidime into extravascular fluid.
    Ryan DM; Mason U; Harding SM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():283-8. PubMed ID: 19802999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermittent administration of ceftazidime to burns patients: influence of glomerular filtration.
    Conil JM; Georges B; Fourcade O; Seguin T; Houin G; Saivin S
    Int J Clin Pharmacol Ther; 2007 Mar; 45(3):133-42. PubMed ID: 17416108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Weibull distribution model for intradermal administration of ceftazidime.
    Bressolle F; Laurelli JM; Gomeni R; Bechier JG; Wynn NR; Galtier M; Eledjam JJ
    J Pharm Sci; 1993 Nov; 82(11):1175-8. PubMed ID: 8289137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Penetration of ceftazidime into bronchial secretions in critically ill patients.
    Langer M; Cantoni P; Bellosta C; Boccazzi A
    J Antimicrob Chemother; 1991 Dec; 28(6):925-32. PubMed ID: 1816189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of cephazolin, ceftazidime, and ceftriaxone distribution in nucleus pulposus.
    Yan D; Li J; Zhang Z; Zhu H
    Arch Orthop Trauma Surg; 2012 Jul; 132(7):969-73. PubMed ID: 22526195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of ceftazidime after a single intramuscular injection in wild turtles.
    Cerreta AJ; Lewbart GA; Dise DR; Papich MG
    J Vet Pharmacol Ther; 2018 Aug; 41(4):495-501. PubMed ID: 29517112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered pharmacokinetics of ceftazidime in critically ill patients.
    Gómez CM; Cordingly JJ; Palazzo MG
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1798-802. PubMed ID: 10390248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Penetration of cefuroxime and ceftazidime into human lungs.
    Perea EJ; Ayarra J; García Iglesias MC; García Luque I; Loscertales J
    Chemotherapy; 1988; 34(1):1-7. PubMed ID: 3280266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetics of ceftazidime in cystic fibrosis].
    Saint Raymond A; Genillier P; Lenoir G
    Presse Med; 1988 Oct; 17(37):1925-7. PubMed ID: 2973587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronokinetics of ceftazidime after intramuscular administration to dogs.
    Monfrinotti A; Ambros L; Montoya L; Prados AP; Rebuelto M
    Chronobiol Int; 2010 May; 27(3):549-59. PubMed ID: 20524800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and tissue penetration of ceftazidime: studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid.
    Walstad RA; Hellum KB; Blika S; Dale LG; Fredriksen T; Myhre KI; Spencer GR
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():275-82. PubMed ID: 6352632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic profiles of ceftazidime in cochlear perilymph, cerebrospinal fluid and plasma: a high-performance liquid chromatographic study.
    Sun AH; Parnes LS; Freeman DJ
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(5):256-9. PubMed ID: 8587777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic studies of ceftazidime in serum, bone, bile, tissue fluid and peritoneal fluid.
    Wittmann DH; Schassan HH; Kohler F; Seibert W
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():293-7. PubMed ID: 19803001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and distribution of ceftazidime to milk after intravenous and intramuscular administration to lactating female dromedary camels (Camelus dromedarius).
    Goudah AM; Hasabelnaby SM
    J Am Vet Med Assoc; 2013 Aug; 243(3):424-9. PubMed ID: 23865886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative analysis of pharmacokinetics of ceftriaxone in serum and pleural fluid in humans: a study of once daily administration by intramuscular and intravenous routes.
    Goonetilleke AK; Dev D; Aziz I; Hughes C; Smith MJ; Basran GS
    J Antimicrob Chemother; 1996 Dec; 38(6):969-76. PubMed ID: 9023644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.